Trademark Overview
On Monday, March 18, 2024, a trademark application was filed for AMGOVO with the United States Patent and Trademark Office. The USPTO has given the AMGOVO trademark a serial number of 98453958. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by Theravance Biopharma R&D IP, LLC. The AMGOVO trademark is filed in the Pharmaceutical Products category with the following description:
Preparations for treatment of human diseases of the autonomic, circulatory, and central nervous system; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents; pharmaceutical preparations and substances for the treatment of Parkinson's disease and disorders; pharmaceutical preparations and substances for the prevention and treatment of dizziness and light-headedness; pharmaceutical preparations and substances for the treatment of disorders characterized by a deficiency of norepinephrine; pharmaceutical preparations and substances for the treatment of multiple system atrophy; pharmaceutical preparations and substances for the treatment of movement disorders; pharmaceutical preparations and substances for the treatment of neurodegene...
